<table id="t3" width="100%" xmlns="urn:hl7-org:v3" xmlns:voc="http://www.hl7.org/v3/voc" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"><caption>Table 3 – Major Outcomes of the NSABP P-1 Trial</caption>
<col align="left" width="15.576%"></col>
<col align="left" width="9.010%"></col>
<col align="left" width="13.110%"></col>
<col align="left" width="12.299%"></col>
<col align="left" width="14.754%"></col>
<col align="left" width="10%"></col>
<col align="left" width="12.176%"></col>
<col align="left" width="10%"></col>
<col align="left" width="22.831%"></col>
<tfoot>
<tr><td align="left" colspan="9" valign="top"><paragraph stylecode="footnote"><sup>1</sup> Two women had hip and wrist fractures</paragraph></td></tr>
<tr><td align="left" colspan="9" valign="top"><paragraph stylecode="footnote"><sup>2</sup> Includes Colles' and other lower radius fractures</paragraph></td></tr>
<tr><td align="left" colspan="9" valign="top"><paragraph stylecode="footnote"><sup>3</sup> Requiring angioplasty or CABG</paragraph></td></tr>
<tr><td align="left" colspan="9" valign="top"><paragraph stylecode="footnote"><sup>4</sup> New Q-wave on ECG; no angina or elevation of serum enzymes; or angina requiring hospitalization without surgery</paragraph></td></tr>
<tr><td align="left" colspan="9" valign="top"><paragraph stylecode="footnote"><sup>5</sup> Seven cases were fatal; three in the placebo group and four in the tamoxifen group</paragraph></td></tr>
<tr><td align="left" colspan="9" valign="top"><paragraph stylecode="footnote"><sup>6</sup> Three cases in the tamoxifen group were fatal</paragraph></td></tr>
<tr><td align="left" colspan="9" valign="top"><paragraph stylecode="footnote"><sup>7</sup> All but three cases in each group required hospitalization</paragraph></td></tr>
<tr><td align="left" colspan="9" valign="top"><paragraph stylecode="footnote"><sup>8</sup> Based on women without cataracts at baseline (6,230-Placebo, 6,199- tamoxifen)</paragraph></td></tr>
<tr><td align="left" colspan="9" valign="top"><paragraph stylecode="footnote"><sup>9</sup> All women (6,707-Placebo, 6,681-tamoxifen)</paragraph></td></tr>
<tr><td align="left" colspan="9" valign="top"><paragraph stylecode="footnote"><sup>10</sup> Updated long-term follow-up data (median 6.9 years) from NSABP P-1 study added after cut-off for the other information in this table.</paragraph></td></tr>
</tfoot>
<tbody>
<tr><td align="left" stylecode="Toprule" valign="top"></td><td align="center" colspan="2" stylecode="Toprule" valign="top"><content stylecode="bold"># Of Events</content></td><td align="center" colspan="4" stylecode="Toprule" valign="top"><content stylecode="bold">Rate/1000 women/Year</content></td><td align="left" colspan="2" stylecode="Toprule" valign="top"></td></tr>
<tr><td align="left" valign="top"></td><td align="center" valign="top"></td><td align="center" valign="top"></td><td align="center" valign="top"></td><td align="center" valign="top"></td><td align="center" colspan="2" valign="top"></td><td align="center" colspan="2" valign="top"><content stylecode="bold">95% CI</content></td></tr>
<tr><td align="left" stylecode="Botrule" valign="top"><content stylecode="bold">Type of Event</content></td><td align="center" stylecode="Botrule" valign="top"><content stylecode="bold">Placebo</content></td><td align="center" stylecode="Botrule" valign="top"><content stylecode="bold">Tamoxifen</content></td><td align="center" stylecode="Botrule" valign="top"><content stylecode="bold">Placebo</content></td><td align="center" stylecode="Botrule" valign="top"><content stylecode="bold">Tamoxifen</content></td><td align="center" colspan="2" stylecode="Botrule" valign="top"><content stylecode="bold">RR</content></td><td align="center" colspan="2" stylecode="Botrule" valign="top"><content stylecode="bold">Limits</content></td></tr>
<tr><td align="left" valign="top"><content stylecode="bold">Invasive Breast Cancer</content></td><td align="center" valign="top">156</td><td align="center" valign="top">86</td><td align="center" valign="top">6.49</td><td align="center" valign="top">3.58</td><td align="center" colspan="2" valign="top">0.56</td><td align="center" colspan="2" valign="top">0.43-0.72</td></tr>
<tr><td align="left" valign="top">   Age ≤49</td><td align="center" valign="top">59</td><td align="center" valign="top">38</td><td align="center" valign="top">6.34</td><td align="center" valign="top">4.11</td><td align="center" colspan="2" valign="top">0.65</td><td align="center" colspan="2" valign="top">0.43-0.98</td></tr>
<tr><td align="left" valign="top">   Age 50-59</td><td align="center" valign="top">46</td><td align="center" valign="top">25</td><td align="center" valign="top">6.31</td><td align="center" valign="top">3.53</td><td align="center" colspan="2" valign="top">0.56</td><td align="center" colspan="2" valign="top">0.35-0.91</td></tr>
<tr><td align="left" valign="top">   Age ≥60</td><td align="center" valign="top">51</td><td align="center" valign="top">23</td><td align="center" valign="top">7.17</td><td align="center" valign="top">3.22</td><td align="center" colspan="2" valign="top">0.45</td><td align="center" colspan="2" valign="top">0.27-0.74</td></tr>
<tr><td align="left" colspan="9" valign="top"><content stylecode="bold">Risk Factors for Breast Cancer History. LCIS</content></td></tr>
<tr><td align="left" valign="top">   No</td><td align="center" valign="top">140</td><td align="center" valign="top">78</td><td align="center" valign="top">6.23</td><td align="center" valign="top">3.51</td><td align="center" colspan="2" valign="top">0.56</td><td align="center" colspan="2" valign="top">0.43-0.74</td></tr>
<tr><td align="left" valign="top">   Yes</td><td align="center" valign="top">16</td><td align="center" valign="top">8</td><td align="center" valign="top">12.73</td><td align="center" valign="top">6.33</td><td align="center" colspan="2" valign="top">0.50</td><td align="center" colspan="2" valign="top">0.21-1.17</td></tr>
<tr><td align="left" valign="top"><content stylecode="bold">History. Atypical Hyperplasia</content></td><td align="center" valign="top"></td><td align="center" valign="top"></td><td align="center" valign="top"></td><td align="center" colspan="2" valign="top"></td><td align="center" colspan="2" valign="top"></td><td align="center" valign="top"></td></tr>
<tr><td align="left" valign="top">   No</td><td align="center" valign="top">138</td><td align="center" valign="top">84</td><td align="center" valign="top">6.37</td><td align="center" valign="top">3.89</td><td align="center" colspan="2" valign="top">0.61</td><td align="center" colspan="2" valign="top">0.47-0.80</td></tr>
<tr><td align="left" valign="top">   Yes</td><td align="center" valign="top">18</td><td align="center" valign="top">2</td><td align="center" valign="top">8.69</td><td align="center" valign="top">1.05</td><td align="center" colspan="2" valign="top">0.12</td><td align="center" colspan="2" valign="top">0.03-0.52</td></tr>
<tr><td align="left" valign="top"><content stylecode="bold"># First Degree Relatives</content></td><td align="center" valign="top"></td><td align="center" valign="top"></td><td align="center" valign="top"></td><td align="center" valign="top"></td><td align="center" colspan="2" valign="top"></td><td align="center" colspan="2" valign="top"></td></tr>
<tr><td align="left" valign="top">   0</td><td align="center" valign="top">32</td><td align="center" valign="top">17</td><td align="center" valign="top">5.97</td><td align="center" valign="top">3.26</td><td align="center" colspan="2" valign="top">0.55</td><td align="center" colspan="2" valign="top">0.30-0.98</td></tr>
<tr><td align="left" valign="top">   1</td><td align="center" valign="top">80</td><td align="center" valign="top">45</td><td align="center" valign="top">5.81</td><td align="center" valign="top">3.31</td><td align="center" colspan="2" valign="top">0.57</td><td align="center" colspan="2" valign="top">0.40-0.82</td></tr>
<tr><td align="left" valign="top">   2</td><td align="center" valign="top">35</td><td align="center" valign="top">18</td><td align="center" valign="top">8.92</td><td align="center" valign="top">4.67</td><td align="center" colspan="2" valign="top">0.52</td><td align="center" colspan="2" valign="top">0.30-0.92</td></tr>
<tr><td align="left" valign="top">   ≥3</td><td align="center" valign="top">9</td><td align="center" valign="top">6</td><td align="center" valign="top">13.33</td><td align="center" valign="top">7.58</td><td align="center" colspan="2" valign="top">0.57</td><td align="center" colspan="2" valign="top">0.20-1.59</td></tr>
<tr><td align="left" colspan="3" valign="top"><content stylecode="bold">5-Year Predicted Breast Cancer Risk (as calculated by the Gail Model)</content></td><td align="center" valign="top"></td><td align="center" valign="top"></td><td align="center" colspan="2" valign="top"></td><td align="center" colspan="2" valign="top"></td></tr>
<tr><td align="left" valign="top">   ≤2.00%</td><td align="center" valign="top">31</td><td align="center" valign="top">13</td><td align="center" valign="top">5.36</td><td align="center" colspan="2" valign="top">2.26</td><td align="center" colspan="2" valign="top">0.42</td><td align="center" valign="top">0.22-0.81</td></tr>
<tr><td align="left" valign="top">   2.01-3.00%</td><td align="center" valign="top">39</td><td align="center" valign="top">28</td><td align="center" valign="top">5.25</td><td align="center" colspan="2" valign="top">3.83</td><td align="center" colspan="2" valign="top">0.73</td><td align="center" valign="top">0.45-1.18</td></tr>
<tr><td align="left" valign="top">   3.01-5.00%</td><td align="center" valign="top">36</td><td align="center" valign="top">26</td><td align="center" valign="top">5.37</td><td align="center" colspan="2" valign="top">4.06</td><td align="center" colspan="2" valign="top">0.76</td><td align="center" valign="top">0.46-1.26</td></tr>
<tr><td align="left" valign="top">   ≥5.00%</td><td align="center" valign="top">50</td><td align="center" valign="top">19</td><td align="center" valign="top">13.15</td><td align="center" colspan="2" valign="top">4.71</td><td align="center" colspan="2" valign="top">0.36</td><td align="center" valign="top">0.21-0.61</td></tr>
<tr><td align="left" valign="top"><content stylecode="bold">DCIS</content></td><td align="center" valign="top">35</td><td align="center" valign="top">23</td><td align="center" valign="top">1.47</td><td align="center" colspan="2" valign="top">0.97</td><td align="center" colspan="2" valign="top">0.66</td><td align="center" valign="top">0.39-1.11</td></tr>
<tr><td align="left" valign="top"><content stylecode="bold">Fractures (protocol-specified sites)</content></td><td align="center" valign="top">92 <sup>1</sup></td><td align="center" valign="top">76 <sup>1</sup></td><td align="center" valign="top">3.87</td><td align="center" colspan="2" valign="top">3.20</td><td align="center" colspan="2" valign="top">0.61</td><td align="center" valign="top">0.83-1.12</td></tr>
<tr><td align="left" valign="top">   Hip</td><td align="center" valign="top">20</td><td align="center" valign="top">9</td><td align="center" valign="top">0.84</td><td align="center" colspan="2" valign="top">0.38</td><td align="center" colspan="2" valign="top">0.45</td><td align="center" valign="top">0.18-1.04</td></tr>
<tr><td align="left" valign="top">   Wrist<sup>2</sup></td><td align="center" valign="top">74</td><td align="center" valign="top">69</td><td align="center" valign="top">3.11</td><td align="center" colspan="2" valign="top">2.91</td><td align="center" colspan="2" valign="top">0.93</td><td align="center" valign="top">0.67-1.29</td></tr>
<tr><td align="left" valign="top"><content stylecode="bold">Total Ischemic Events</content></td><td align="center" valign="top">59</td><td align="center" valign="top">61</td><td align="center" valign="top">2.47</td><td align="center" colspan="2" valign="top">2.57</td><td align="center" colspan="2" valign="top">1.04</td><td align="center" valign="top">0.71-1.51</td></tr>
<tr><td align="left" valign="top">   Myocardial Infarction</td><td align="center" valign="top">27</td><td align="center" valign="top">27</td><td align="center" valign="top">1.13</td><td align="center" colspan="2" valign="top">1.13</td><td align="center" colspan="2" valign="top">1.00</td><td align="center" valign="top">0.57-1.78</td></tr>
<tr><td align="left" valign="top">     Fatal</td><td align="center" valign="top">8</td><td align="center" valign="top">7</td><td align="center" valign="top">0.33</td><td align="center" colspan="2" valign="top">0.29</td><td align="center" colspan="2" valign="top">0.88</td><td align="center" valign="top">0.27-2.77</td></tr>
<tr><td align="left" valign="top">     Nonfatal</td><td align="center" valign="top">19</td><td align="center" valign="top">20</td><td align="center" valign="top">0.79</td><td align="center" colspan="2" valign="top">0.84</td><td align="center" colspan="2" valign="top">1.06</td><td align="center" valign="top">0.54-2.09</td></tr>
<tr><td align="left" valign="top">   Angina <sup>3</sup></td><td align="center" valign="top">12</td><td align="center" valign="top">12</td><td align="center" valign="top">0.50</td><td align="center" colspan="2" valign="top">0.50</td><td align="center" colspan="2" valign="top">1.00</td><td align="center" valign="top">0.41-2.44</td></tr>
<tr><td align="left" valign="top">   Acute Ischemic Syndrome <sup>4</sup></td><td align="center" valign="top">20</td><td align="center" valign="top">22</td><td align="center" valign="top">0.84</td><td align="center" colspan="2" valign="top">0.92</td><td align="center" colspan="2" valign="top">1.11</td><td align="center" valign="top">0.58-2.13</td></tr>
<tr><td align="left" valign="top"><content stylecode="bold">Uterine</content></td><td align="center" valign="top"></td><td align="center" valign="top"></td><td align="center" valign="top"></td><td align="center" colspan="2" valign="top"></td><td align="center" colspan="2" valign="top"></td><td align="center" valign="top"></td></tr>
<tr><td align="left" valign="top">   <content stylecode="bold">Malignancies (among women</content></td><td align="center" valign="top">17</td><td align="center" valign="top">57</td><td align="center" valign="top"></td><td align="center" colspan="2" valign="top"></td><td align="center" colspan="2" valign="top"></td><td align="center" valign="top"></td></tr>
<tr><td align="left" valign="top">   <content stylecode="bold">with an intact uterus)</content><sup>10</sup></td><td align="center" valign="top"></td><td align="center" valign="top"></td><td align="center" valign="top"></td><td align="center" colspan="2" valign="top"></td><td align="center" colspan="2" valign="top"></td><td align="center" valign="top"></td></tr>
<tr><td align="left" valign="top"><content stylecode="bold">Endometrial Adenocarcinoma</content><sup>10</sup></td><td align="center" valign="top">17</td><td align="center" valign="top">53</td><td align="center" valign="top">0.71</td><td align="center" colspan="2" valign="top">2.20</td><td align="center" colspan="2" valign="top"></td><td align="center" valign="top"></td></tr>
<tr><td align="left" valign="top"><content stylecode="bold">Uterine Sarcoma</content><sup>10</sup></td><td align="center" valign="top">0</td><td align="center" valign="top">4</td><td align="center" valign="top">0.0</td><td align="center" colspan="2" valign="top">0.17</td><td align="center" colspan="2" valign="top"></td><td align="center" valign="top"></td></tr>
<tr><td align="left" valign="top"><content stylecode="bold">Stroke</content><sup>5</sup></td><td align="center" valign="top">24</td><td align="center" valign="top">34</td><td align="center" valign="top">1.00</td><td align="center" colspan="2" valign="top">1.43</td><td align="center" colspan="2" valign="top">1.42</td><td align="center" valign="top">0.82-2.51</td></tr>
<tr><td align="left" valign="top"><content stylecode="bold">Transient Ischemic Attack</content></td><td align="center" valign="top">21</td><td align="center" valign="top">18</td><td align="center" valign="top">0.88</td><td align="center" colspan="2" valign="top">0.75</td><td align="center" colspan="2" valign="top">0.86</td><td align="center" valign="top">0.43-1.70</td></tr>
<tr><td align="left" valign="top"><content stylecode="bold">Pulmonary Emboli</content><sup>6</sup></td><td align="center" valign="top">6</td><td align="center" valign="top">18</td><td align="center" valign="top">0.25</td><td align="center" colspan="2" valign="top">0.75</td><td align="center" colspan="2" valign="top">3.01</td><td align="center" valign="top">1.15-9.27</td></tr>
<tr><td align="left" valign="top"><content stylecode="bold">Deep-Vein Thrombosis</content><sup>7</sup></td><td align="center" valign="top">19</td><td align="center" valign="top">30</td><td align="center" valign="top">0.79</td><td align="center" colspan="2" valign="top">1.26</td><td align="center" colspan="2" valign="top">1.59</td><td align="center" valign="top">0.86-2.98</td></tr>
<tr><td align="left" valign="top"><content stylecode="bold">Cataracts Developing on Study</content><sup>8</sup></td><td align="center" valign="top">483</td><td align="center" valign="top">540</td><td align="center" valign="top">22.51</td><td align="center" colspan="2" valign="top">25.41</td><td align="center" colspan="2" valign="top">1.13</td><td align="center" valign="top">1.00-1.28</td></tr>
<tr><td align="left" valign="top"><content stylecode="bold">Underwent Cataract Surgery</content><sup>8</sup></td><td align="center" valign="top">63</td><td align="center" valign="top">101</td><td align="center" valign="top">21.83</td><td align="center" colspan="2" valign="top">4.57</td><td align="center" colspan="2" valign="top">1.62</td><td align="center" valign="top">1.18-2.22</td></tr>
<tr><td align="left" stylecode="Botrule" valign="top"><content stylecode="bold">Underwent Cataract Surgery</content><sup>9</sup></td><td align="center" stylecode="Botrule" valign="top">129</td><td align="center" stylecode="Botrule" valign="top">201</td><td align="center" stylecode="Botrule" valign="top">5.44</td><td align="center" colspan="2" stylecode="Botrule" valign="top">8.56</td><td align="center" colspan="2" stylecode="Botrule" valign="top">1.58</td><td align="center" stylecode="Botrule" valign="top">1.26-1.97</td></tr>
</tbody>
</table>